Nkarta, Inc. SEC filings NKTX
Nkarta, Inc. has 438 filings in SEC EDGAR's recent list, going back to Sep 6, 2019. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Apr 3, 2026 | — |
| S-3 | Shelf registration | Mar 25, 2026 | — |
| S-8 | Employee stock plan registration | Jan 5, 2026 | — |
| S-8 | Employee stock plan registration | Jan 2, 2025 | — |
| 424B5 | Prospectus supplement | Mar 26, 2024 | — |
| S-8 | Employee stock plan registration | Jan 3, 2024 | — |
| S-3/A | Filing | Apr 24, 2023 | — |
| S-3 | Shelf registration | Mar 17, 2023 | — |
| S-8 | Employee stock plan registration | Jan 9, 2023 | — |
| 424B5 | Prospectus supplement | Apr 26, 2022 | — |
| 424B5 | Prospectus supplement | Apr 25, 2022 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| 424B5 | Prospectus supplement | Sep 3, 2021 | — |
| S-3 | Shelf registration | Aug 12, 2021 | — |
| S-8 | Employee stock plan registration | Jan 15, 2021 | — |
| S-8 | Employee stock plan registration | Aug 3, 2020 | — |
| 424B4 | Prospectus | Jul 13, 2020 | — |
| S-1MEF | Filing | Jul 10, 2020 | — |
| S-1/A | Amended registration statement | Jul 9, 2020 | — |
| S-1/A | Amended registration statement | Jul 9, 2020 | — |
| S-1/A | Amended registration statement | Jul 2, 2020 | — |
| S-1 | Registration statement | Jun 19, 2020 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NKTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1787400
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.